研究单位：[1]Zhongshan Ophthalmic Center, Sun Yat-sen University[2]GuangZhou WeiShiBo Biotechnology Co., ltd[3]Beijing Tongren Hospital,Beijing,China,100730[4]Peking Union Medical College Hospital,Peking,Beijing,China,100032[5]Southwest Hospital,Chongqing,Chongqing,China,400038[6]Zhongshan Ophthalmic Center, Sun Yat-sen University,GuangZhou,Guangdong,China,510000[7]The 2nd affiliated hospital of Harbin Medicinal University.,Harbin,Heilongjiang,China,150001[8]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430060[9]Eye and ENT Hospital of FuDan University,Shanghai,Shanghai,China,200031[10]XiJing Hospital,Xian,Shanxi,China,710032[11]The affiliated Eye Hospital of Wenzhou Medical College,Wenzhou,Zhejiang,China,325027
The purpose of this study is to determine the feasibility, primary safety and efficacy of foldable capsular vitreous body (FCVB) in the treatment of retinal detachment, based on the multi-center clinical trial.
